# Steroid Injections vs. Standard Treatment for Macular Edema Due to Retinal Blood Vessel Blockage

> **NCT00106132** · PHASE3 · COMPLETED · sponsor: **National Eye Institute (NEI)** · enrollment: 1260 (—)

## Conditions studied

- Retinal Vein Occlusion
- Macular Edema, Cystoid
- Macular Edema

## Interventions

- **DRUG:** Triamcinolone Acetonide

## Key facts

- **NCT ID:** NCT00106132
- **Lead sponsor:** National Eye Institute (NEI)
- **Sponsor class:** NIH
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-03
- **Primary completion:** —
- **Final completion:** 2005-11
- **Target enrollment:** 1260 (—)
- **Last updated:** 2008-03-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00106132

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00106132, "Steroid Injections vs. Standard Treatment for Macular Edema Due to Retinal Blood Vessel Blockage". Retrieved via AI Analytics 2026-07-09 from https://api.ai-analytics.org/clinical/NCT00106132. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
